InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,698.80
(
1.37%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
71.81
(
-1.89%
)
Bitcoin
64,074.47
(
1.49%
)
Post# of 43374
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

10nisman

Send PM Follow Ignore
Followers 26
Posts 2534
Boards Moderated 0
Alias Born 10/26/2003

10nisman

Re: DonDonDonDon post# 29857

Saturday, 05/29/2021 10:52:24 AM

Saturday, May 29, 2021 10:52:24 AM

Post# of 43374
"We are committed to getting lenzilumab into the hands of medical professionals for the treatment of COVID-19. It is anticipated that thousands of patients will continue to be hospitalized daily, some of whom may benefit from lenzilumab."

Except hospitalizations are falling significantly (only 27,000 total today) and there will be less than a 1,000 new cases per day in the U.S. by July (if not sooner) and at best a very small portion of those patients May benefit from Lenz. The pool of patients is shrinking everyday...
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up